NiKem Research is pleased to announce that it has received on March 29th 2010, from the Italian Ministry of Health (Decree N. 69/2010-B), the authorization to perform acute and sub-chronic toxicology studies (upto 28 days) in all rodent species for preliminary safety evaluation of novel chemical entities (NCEs). Toxicokinetic (TK) studies are also allowed to correlate plasma and/or organ exposure of NCEs (and metabolites) to tolerated doses in toxicology studies.
View or download the full press release here »

NiKem Research Receives Qualification for Bioanalysis of Clinical Samples (April 12th, 2010)
NiKem Research receives certification for GLP Bioanalysis (September 14th, 2009)
NiKem Research further extends its ADMET and in vivo assay capabilities (April 2009)
NiKem Research Srl Enters Into Research Service Agreement with InterMune Inc (June 25th, 2007)
Brane Discovery launched as spin out of R&D programmes from Nikem Research (April 23rd, 2007)
Neurotune AG and NiKem Research SRL Enter Into a Research Service Agreement (April 2nd, 2007)
NiKem Research S.r.l. appoints Pierfausto Seneci as Chief Business Officer
(May 31st, 2005)
NiKem Research and Chiesi Farmaceutici Enter into a New Research Collaboration(February 18th, 2004)
NiKem Research and GSK Enter into a Research Partnership Agreement (January 8th, 2004)
NiKem Research Introduces the Explora ADMET Service (September 3rd, 2003)
NiKem Research Announces New Research Collaborations with GSK
(August 1st, 2003)
NiKem Research Enters into a Research Services Agreement with Wyeth
(May 12th, 2003)
NiKem Research Acquires a Patent Portfolio of V-ATPase Inhibitors from GSK (February 19th, 2003)